Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β
Tóm tắt
The rat estrogen receptor (ER) exists as two subtypes, ERα and ERβ, which differ in the C-terminal ligand binding domain and in the N-terminal transactivation domain. In this study we investigated the messenger RNA expression of both ER subtypes in rat tissues by RT-PCR and compared the ligand binding specificity of the ER subtypes.
Saturation ligand binding analysis of in vitro synthesized human ERα and rat ERβ protein revealed a single binding component for 16α-iodo-17β-estradiol with high affinity[ dissociation constant (Kd) = 0.1 nm for ERα protein and 0.4 nm for ERβ protein]. Most estrogenic substances or estrogenic antagonists compete with 16α-[125I]iodo-17β-estradiol for binding to both ER subtypes in a very similar preference and degree; that is, diethylstilbestrol > hexestrol > dienestrol > 4-OH-tamoxifen > 17β-estradiol > coumestrol, ICI-164384 > estrone, 17α-estradiol > nafoxidine, moxestrol > clomifene > estriol, 4-OH-estradiol > tamoxifen, 2-OH-estradiol, 5-androstene-3β,17β-diol, genistein for the ERα protein and dienestrol > 4-OH-tamoxifen > diethylstilbestrol > hexestrol > coumestrol, ICI-164384 > 17β-estradiol > estrone, genistein > estriol > nafoxidine, 5-androstene-3β,17β-diol > 17α-estradiol, clomifene, 2-OH-estradiol > 4-OH-estradiol, tamoxifen, moxestrol for the ERβ protein. The rat tissue distribution and/or the relative level of ERα and ERβ expression seems to be quite different, i.e. moderate to high expression in uterus, testis, pituitary, ovary, kidney, epididymis, and adrenal for ERα and prostate, ovary, lung, bladder, brain, uterus, and testis for ERβ. The described differences between the ER subtypes in relative ligand binding affinity and tissue distribution could contribute to the selective action of ER agonists and antagonists in different tissues.
Từ khóa
Tài liệu tham khảo
Clark, 1992, Mechanisms of action of steroid hormones, In: Wilson J, Foster DW (eds) Textbook of Endocrinology. WB Saunders Company, Philadelphia, pp, 35
Murdoch, 1991, The role of ligand in estrogen receptor regulation of gene expression, Mol Cell Endocrinol, 78, C103, 10.1016/0303-7207(91)90114-8
Koike, 1987, Molecular cloning and characterization of rat estrogen receptor cDNA., Nucleic Acids Res, 15, 2499, 10.1093/nar/15.6.2499
Kuiper, 1996, Cloning of a novel estrogen receptor expressed in rat prostate and ovary., Proc Natl Acad Sci USA, 93, 5925, 10.1073/pnas.93.12.5925
Katzenellenbogen, 1996, Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones., Mol Endocrinol, 10, 119
Gronemeyer, 1995, Transcription factors 3: nuclear receptors., Protein Profiles, 2, 1173
Seielstad, 1995, Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis., Biochemistry, 34, 12605, 10.1021/bi00039a016
Korach, 1995, Estrogens, In: Munson PL (ed) Principles of Pharmacology. Basic Concepts and Clinical Applications. Chapman and Hall, New York, pp, 809
Jordan, 1995, Antiestrogens, In: Munson PL (ed) Principles of Pharmacology. Basic Concepts and Clinical Applications. Chapman and Hall, New York, pp, 827
Beekman, 1993, Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain., Mol Endocrinol, 7, 1266
Salomonsson, 1994, Equilibrium hormone binding to human estrogen receptors in highly diluted cell extracts is non-cooperative and has a Kd of approximately 10 pm., J Steroid Biochem Mol Biol, 50, 313, 10.1016/0960-0760(94)90137-6
Wells, 1992, Analysis and interpretation of binding at equilibrium, In: Hulme EC (ed) Receptor Ligand Interactions. A Practical Approach. IRL Press, Oxford UK, pp, 289
Hulme, 1992, Strategy and tactics in receptor-binding studies, In: Hulme EC (ed) Receptor Ligand Interactions. A Practical Approach. IRL Press, Oxford UK, pp, 163
Schults, 1988, Pharmaceutical lead discovery and optimization, In: Peace KE (ed) Biopharmaceutical Statistics for Drug Development. Marcel Dekker, New York, pp, 21
Chomczynski, 1987, Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction., Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2
Grandien, 1995, Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines., Endocrinology, 136, 2223, 10.1210/endo.136.5.7720671
Grandien, 1993, Localization of DNase I hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promoters., J Mol Endocrinol, 10, 269, 10.1677/jme.0.0100269
Hochberg, 1980, Interaction of 16α-[125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins., Proc Natl Acad Sci USA, 77, 328, 10.1073/pnas.77.1.328
Berns, 1985, Rapid and sensitive detection of oestrogen receptors in cells and tissue sections by autoradiography with [125I]-oestradiol., Histochem J, 17, 1185, 10.1007/BF01002501
Noteboom, 1965, Stereospecific binding of estrogens in the rat uterus., Arch Biochem Biophys, 111, 559, 10.1016/0003-9861(65)90235-3
Hähnel, 1973, The specificity of the estrogen receptor of human uterus., J Steroid Biochem, 4, 21, 10.1016/0022-4731(73)90076-9
Pieslor, 1982, Three radioligands compared for determining cytoplasmic estrogen receptor content of human breast carcinomas., Clin Chem, 28, 532, 10.1093/clinchem/28.3.532
Wakeling, 1996, Physiological effects of pure antiestrogens, In: Katzenellenbogen BS, Pasqualini JR (eds) Hormone-Dependent Cancer. Marcel Dekker, New York, pp, 107
Huggins, 1954, Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat., J Exp Med, 100, 225, 10.1084/jem.100.3.225
Garcia, 1979, Evidence and characterization of the binding of two 3H-labeled androgens to the estrogen receptor., Endocrinology, 104, 1797, 10.1210/endo-104-6-1797
Doorn, 1981, Actions and interactions of 5-androstene-3β,17β-diol and 17β-estradiol in the immature rat uterus., Endocrinology, 108, 1587, 10.1210/endo-108-4-1587
Botella, 1995, Lack of estrogenic potential of progesterone or 19-Nor-progesterone-derived progestins as opposed to testosterone or 19-Nor-testosterone derivatives on endometrial Ishikawa cells., J Steroid Biochem Mol Biol, 55, 77, 10.1016/0960-0760(95)00156-T
Mäkelä,, 1994, Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells., Environ Health Perspect, 102, 572, 10.1289/ehp.94102572
Adlercreutz, 1993, Plasma concentrations of phyto-estrogens in Japanese men., Lancet, 342, 1209, 10.1016/0140-6736(93)92188-Y
Katzenellenbogen, 1979, Zearalenones: characterization of the estrogenic potenties and receptor interactions of a series of fungal β-resorcylic acid lactones., Endocrinology, 105, 33, 10.1210/endo-105-1-33
Kelce, 1995, Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist., Nature, 375, 581, 10.1038/375581a0
Arnold, 1996, Synergistic activation of estrogen receptor with combinations of environmental chemicals., Science, 272, 1489, 10.1126/science.272.5267.1489
Beurden-Lamers, 1974, High-affinity binding of oestradiol-17β by cytosols from testis interstitial tissue, pituitary, adrenal, liver and accessory sex glands of the male rat., Biochem J, 140, 495, 10.1042/bj1400495
Morishige, 1978, Receptors for androgen and estrogen in the rat lung., Endocrinology, 102, 1827, 10.1210/endo-102-6-1827
Notides, 1970, Binding affinity and specificity of the estrogen receptor of the rat uterus and anterior pituitary., Endocrinology, 87, 987, 10.1210/endo-87-5-987
Swillens, 1995, Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites?, Trends Pharmaceutical Sci, 16, 151, 10.1016/S0165-6147(00)89007-0
Prins, 1995, The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen., Endocrinology, 136, 1303, 10.1210/endo.136.3.7867585
Brolin, 1992, Immunohistochemistry and biochemistry in detection of androgen, progesterone and estrogen receptors in benign and malignant human prostatic tissues., Prostate, 20, 281, 10.1002/pros.2990200404
Kudolo, 1984, A novel oestrogen-binding species in rat granulosa cells., J Endocrinol, 102, 83, 10.1677/joe.0.1020083
Hild-Petito, 1988, Immuno-cytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle., Endocrinology, 123, 2896, 10.1210/endo-123-6-2896
Greene, 1982, Monoclonal antibodies as probes for estrogen receptor detection and characterization., J Steroid Biochem, 16, 353, 10.1016/0022-4731(82)90045-0
Lubahn, 1993, Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene., Proc Natl Acad Sci USA, 90, 11162, 10.1073/pnas.90.23.11162
Merchenthaler, 1996, 744